Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Adrenocorticotropic hormone inhibits growth and affects body composition in male rats.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Testosterone is important for male sexual traits, reproduction, muscle and bone health, blood production, and metabolism, and works both directly and after being changed into other hormones.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Researchers made two new compounds that could be used for medicine.

Nandrolone phenylpropionate injections thickened the skin and enlarged oil glands in female hairless hamsters.

Supplements improve health, appearance, and athletic performance.